US2023079113A1PendingUtilityA1
Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis
Est. expiryFeb 1, 2032(~5.6 yrs left)· nominal 20-yr term from priority
A61K 35/15A61L 27/3834A61K 38/39A61L 27/24A61L 2430/24A61L 27/54A61L 27/3691A61L 2400/06A61K 2035/124A61P 19/02A61L 27/3804A61K 38/18A61L 27/3633A61L 27/56A61L 2300/414A61K 35/19
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides biomaterials and methods for preventing and minimizing progression of cartilage and/or connective tissue damage. Also provided herein are biomaterials and methods for alleviating and/or reducing the risk for developing arthritis (e.g., osteoarthritis) associated with joint injury and/or joint surgery.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating arthritis, comprising administering to a joint of a subject that has or is at risk for developing arthritis at the joint an effective amount of a collagen material; wherein the subject is not concurrently surgically treated to repair a torn, fractured, strained, bruised, or ruptured intra-articular tissue.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.